ULTIMOVACS ASA

ULTI
Real-time Quote. Real-time  - 10/19 10:25:12 am
134.4NOK +3.07%

Turn to zoom
Prev.130.4000
Open132.6000
High140.6000
Low131.6000
Volume167 384
Latest news
4d ago
5d ago
6d ago
6d ago
Chart ULTIMOVACS ASA
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance162162160
Spread/Res.-17%-17%-16%
Spread/Supp.3,5%42%53%
Support13094,787,8
Financials
Sales 2021 - - -
Net income 2021 -151 M -18,1 M -18,1 M
Net cash 2021 296 M 35,4 M 35,4 M
P/E ratio 2021 -27,6x
Yield 2021 -
Capitalization 4 181 M 500 M 500 M
EV / Sales 2021 -
EV / Sales 2022 -
Nbr of Employees 21
Free-Float 56,4%
Company
Ultimovacs ASA, formerly Ultimovacs AS, is a Norway-based pharmaceutical company developing immunotherapies against cancer. The Company's lead product candidate is UV1, a peptide-based vaccine inducing a specific T cell response against the universal cancer antigen telomerase. UV1 is being...

>> Read more
Sector :
Other Biotechnology & Medical Research
Calendar :
No events available

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 130,40 NOK
Average target price 200,00 NOK
Spread / Average Target 53,4%